Two Decades of Life-Saving Treatment
3 Articles
3 Articles
The U.S. Food and Drug Administration (FDA) has conditionally approved a novel melanoma combination therapy developed by the U.S. biotech company Replimune, after rejecting it twice. Confirmatory clinical trials to demonstrate actual clinical significance remain. As combination therapies combining existing anticancer drugs with novel substances, like Replimune's, emerge as a new strategy for melanoma treatment, domestic pharmaceutical and biotec…
Starting in September of this year, new reimbursed medicines intended for the treatment of various oncological diseases will become available to patients, as well as to patients who fail to reduce "bad" (LDL) cholesterol with other medications, and to children with growth disorders, the Ministry of Health announces.
Two decades of life-saving treatment
By PEACE IJIYERA GIPPSLAND Cancer Care Centre (GCCC) celebrated its 20th anniversary on July 31. The centre, located at Latrobe Regional Health (LRH), was officially opened on May 17, 2006. Since then, the centre has helped many patients and families around Gippsland in providing cancer treatment, but more importantly, providing cancer treatment close to home. Invited to the celebrations were patients, families, staff and everyone who had be…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
